Treatment With Valoctocogene Roxaparvovec in a Patient With Severe Hemophilia A Led to Sustained Normal FVIII Levels.
Haemophilia : the official journal of the World Federation of Hemophilia
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publicationInfection
View this publicationCritical care (London, England)
View this publicationMolecular metabolism
View this publicationNature aging
View this publicationJournal of bacteriology
View this publicationExpert review of hematology
View this publicationInternational journal of cancer
View this publicationClinical drug investigation
View this publicationCellular immunology
View this publication